13F HOLDINGS REPORT
Foresite Capital Management IV, LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001104659-25-049390
Total Value
$111.1M
Positions
5
Other Managers
0
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Pharvaris N.V. | PHVS | 4,410,581 | $69.2M | 62.35% |
| 2 | Maze Therapeutics Inc | MAZE | 2,111,919 | $23.3M | 20.93% |
| 3 | Lyell Immunopharma, Inc. | LYEL | 16,007,999 | $8.6M | 7.75% |
| 4 | Kura Oncology, Inc. | KURA | 1,111,882 | $7.3M | 6.61% |
| 5 | Relay Therapeutics Inc. | RLAY | 1,000,000 | $2.6M | 2.36% |